SOCS3 is associated with the IL-6–STAT3 pathway in insulin signaling (Senn et al., 2003) and has been reported to be increased in the skeletal muscle of severely obese or type 2 diabetes patients (Steinberg et al., 2006; Jorgensen et al., 2013). This evidence concerns the gene INS and type 2 diabetes mellitus.